These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32386943)

  • 1. Complete response to the combination of sintilimab and IBI305 for a patient with HBV-associated hepatocellular carcinoma with multiple lung metastasis.
    Duan X; Zhang H; Zhou L; Jiang B; Mao X
    Dig Liver Dis; 2020 Jul; 52(7):794-796. PubMed ID: 32386943
    [No Abstract]   [Full Text] [Related]  

  • 2. Sintilimab plus sorafenib: a novel regimen for hepatocellular carcinoma.
    Liu X; Yi Y
    Immunotherapy; 2021 Dec; 13(17):1387-1393. PubMed ID: 34665016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of advanced hepatocellular carcinoma with lung metastases and cirrhosis that responded to combination chemotherapy with interferon-alpha and 5-fluorouracil].
    Shitara K; Munakata M; Kudo T; Muto O; Okada R; Mitobe S; Sakata Y; Kondo M; Ishii E; Yabu K
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2083-6. PubMed ID: 17197759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sintilimab plus IBI305 for hepatocellular carcinoma.
    Cheng L; Xiao H
    Lancet Oncol; 2021 Sep; 22(9):e387. PubMed ID: 34478671
    [No Abstract]   [Full Text] [Related]  

  • 5. Sintilimab plus IBI305 for hepatocellular carcinoma.
    Bomze D; Meirson T; Azoulay D
    Lancet Oncol; 2021 Sep; 22(9):e386. PubMed ID: 34478670
    [No Abstract]   [Full Text] [Related]  

  • 6. Sintilimab plus IBI305 for hepatocellular carcinoma - Author's reply.
    Fan J
    Lancet Oncol; 2021 Sep; 22(9):e388. PubMed ID: 34478672
    [No Abstract]   [Full Text] [Related]  

  • 7. Complete Response to the Combination of Pembrolizumab and Sorafenib for Metastatic Hepatocellular Carcinoma: A Case Report.
    Chen SC; Chao Y; Yang MH
    Am J Gastroenterol; 2017 Apr; 112(4):659-660. PubMed ID: 28381841
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
    Tsurumachi T; Yamamoto H; Watanabe K; Honda I; Watanabe S; Yamada S; Jingu K; Satomi D; Fujita M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):631-4. PubMed ID: 8678524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the editor: Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study-Should we extend the boundaries?
    Gulati P; Taneja S; Duseja A; Singh V
    Hepatology; 2022 Oct; 76(4):E80-E81. PubMed ID: 35503726
    [No Abstract]   [Full Text] [Related]  

  • 10. Atezolizumab plus bevacizumab for advanced, unresectable hepatocellular carcinoma.
    Tsilimigras DI; Moris D
    J BUON; 2021; 26(2):637. PubMed ID: 34077021
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complete response of a massive hepatocellular carcinoma with lung metastasis to UFT (DPD inhibitory fluoroprymidines: DIF)].
    Haseme E; Shohkei O; Ohnishi Y; Kikuchi K
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):247-51. PubMed ID: 11242656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study.
    Lee MS; Ryoo BY; Hsu CH; Numata K; Stein S; Verret W; Hack SP; Spahn J; Liu B; Abdullah H; Wang Y; He AR; Lee KH;
    Lancet Oncol; 2020 Jun; 21(6):808-820. PubMed ID: 32502443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report.
    Inuzuka T; Nishikawa H; Sekikawa A; Takeda H; Henmi S; Sakamoto A; Saito S; Kita R; Kimura T; Osaki Y; Kudo M
    Oncology; 2011; 81 Suppl 1():152-7. PubMed ID: 22212950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?
    Trojan J; Sarrazin C
    Am J Gastroenterol; 2016 Aug; 111(8):1208-9. PubMed ID: 27481429
    [No Abstract]   [Full Text] [Related]  

  • 15. Determining the Efficacy of Pembrolizumab in Patients With Previously Treated Advanced Hepatocellular Carcinoma.
    Lin TA; Das A; McCaw Z; Ludmir EB
    J Clin Oncol; 2023 Jun; 41(16):3074-3075. PubMed ID: 37015029
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathology of hepatitis B virus-related hepatocellular carcinoma with a comparison to hepatitis C virus-related hepatocellular carcinoma].
    Kojiro M; Nakashima O; Takazawa T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):713-7. PubMed ID: 12442472
    [No Abstract]   [Full Text] [Related]  

  • 17. Solitary pulmonary metastasis arising thirteen years after liver transplantation for HBV-related hepatocellular carcinoma.
    Viola C; Asselah T; Samuel D; Durand F; Boudjema H; Valla D; Marcellin P
    World J Gastroenterol; 2006 Aug; 12(30):4911-3. PubMed ID: 16937481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients.
    Zhang W; Gong C; Peng X; Bi X; Sun Y; Zhou J; Wu F; Zeng H; Wang Y; Zhou H; Zhao H; Cai J; Zhou A
    Clin Cancer Res; 2022 Aug; 28(16):3499-3508. PubMed ID: 35275208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancoast syndrome caused by metastasis to the superior mediastinum of hepatocellular carcinoma.
    Hung JJ; Lin SC; Hsu WH
    Thorac Cardiovasc Surg; 2007 Oct; 55(7):463-5. PubMed ID: 17902073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complete disappearance of metastatic lung tumors and mediastinal lymphnode in a case of hepatocellular carcinoma treated by low-dose 5-fluorouracil/cisplatin therapy].
    Anami Y; Oguma S; Matsuda Y; Yamaki T; Sazawa Y; Komiya H; Izai J; Ota T
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1977-80. PubMed ID: 16282739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.